NR3C2 and obstructive sleep apnea syndrome: This review focuses on the relationship between the OSA and MR activation, mechanisms shared by both conditions in promoting CVD, and the potential cardiovascular benefits of MR antagonism, thus highlighting MR as a potential therapeutic target for OSA-induced CVD.